The Outcomes of Induction Chemoradiotherapy Followed by Surgery for Clinical T3-4 Non-Small Cell Lung Cancer.
Ryu KanzakiNaoko OseSoichiro FunakiYasushi ShintaniMasato MinamiOsamu SuzukiHiroshi KidaKazuhiko OgawaAtsushi KumanogohMeinoshin OkumuraPublished in: Technology in cancer research & treatment (2020)
Induction chemoradiotherapy followed by surgery for cT3-4 non-small cell lung cancer could be performed with an acceptable degree of surgical risk. At present, it is thought to be one of the reasonable treatment approaches for selected patients with cT3-4 disease, even those with a cN0-1 status.
Keyphrases
- minimally invasive
- coronary artery bypass
- rectal cancer
- image quality
- computed tomography
- locally advanced
- dual energy
- contrast enhanced
- positron emission tomography
- squamous cell carcinoma
- magnetic resonance imaging
- magnetic resonance
- lymph node metastasis
- percutaneous coronary intervention
- type diabetes
- adipose tissue
- acute coronary syndrome
- skeletal muscle
- replacement therapy
- smoking cessation
- glycemic control